27/11/2019
The Human Resources Strategy for Researchers
Marie Skłodowska-Curie Actions

15 Early Stage Researcher (ESR) 3-year PhD positions - BactiVax European Training Network

This job offer has expired


  • ORGANISATION/COMPANY
    Univ. College Dublin
  • RESEARCH FIELD
    Biological sciences
    Chemistry
    Medical sciences
  • RESEARCHER PROFILE
    First Stage Researcher (R1)
  • APPLICATION DEADLINE
    31/12/2019 23:00 - Europe/London
  • LOCATION
    Multiple locations, see work locations below.
  • TYPE OF CONTRACT
    Temporary
  • JOB STATUS
    Full-time
  • HOURS PER WEEK
    40
  • OFFER STARTING DATE
    01/04/2020
  • EU RESEARCH FRAMEWORK PROGRAMME
    H2020 / Marie Skłodowska-Curie Actions
  • MARIE CURIE GRANT AGREEMENT NUMBER
    860325

Applications are invited for 15 three-year PhD studentships to be funded by the Marie- Skłodowska-Curie Innovative Training Network “BactiVax” within the Horizon 2020 Programme of the European Commission.

BactiVax (anti-Bacterial Innovative Vaccines) is an innovative European Training Network that will provide high-level training in vaccinology to 15 high-achieving, creative Early Stage Researchers (ESRs), and equip them with a wide range of transferrable skills for thriving careers in vaccine research within academia and industry. BactiVax will focus on developing novel vaccines to tackle the huge challenge of antimicrobial-resistant human pathogens that cause chronic, life-threatening respiratory and/or systemic infections. This network comprises 14 Principal Investigators with expertise in vaccinology, proteomics, medicine, microbiology, biochemistry, immunology, structural biology, medicinal, peptide and glycochemistry from 8 European countries and two companies which will collectively train ESRs in entrepreneurship, commercial vaccine development and bioprocessing.

Participant organisations and principal investigators

Eligibility criteria for candidates

We are looking for talented and highly motivated early career researchers with an Honours BSc and/or MSc degree and experience in biology, infection & immunity, biochemistry, microbiology, pharmacology, organic synthesis, glycochemistry, drug delivery or related subjects.

Successful applicants will be offered a 36-month employee contract at one of the partner institutions where they will be registered as PhD students. ESRs will receive a salary set out by the Marie Skłodowska-Curie Actions (MSCA) regulations. The salary includes living and mobility allowances and, if appropriate, a family allowance.

Please note that all criteria below are mandatory:

1. Applicants should, at the time of recruitment, be in the first four years (full time equivalent research experience) of their research careers and not have been awarded a doctorate.

2. At the time of recruitment by the host organisation, they must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organisation for more than 12 months in the 3 years immediately prior to the recruitment date. Compulsory national service, short stays such as holidays, and time spent as part of a procedure for obtaining refugee status under the Geneva Convention are not taken into account.

3. Admission to the programme is open to applicants who hold a bachelor’s and/or master’s degree. A minimum of 240 ECTS and four years of legal duration in total is mandatory (please see each project for institutional requirements) or a comparable university degree (Second Cycle qualification), as required by the partner universities for admission to doctoral studies. The above-mentioned degrees must be obtained by the time of recruitment.

4. Requirements set by the consortium include a minimum of BSc Honours 2.1 and/or MSc degree (or equivalent) graduates in the fields of chemistry, medicinal chemistry, pharmacology, biochemistry, biology, microbiology, biomedical and biopharmaceutical sciences, medicine.

5. Applicants should be proficient in written and spoken English (minimum level of B2 or equivalent). Those who have passed an English proficiency test such as (but not limited to) IELTS Academic or TOEFL should enclose the relevant certificate with their application. English proficiency of short-listed applicants will be assessed during the selection interview. Please note that English-speaking countries might have specific language requirements.

Application and selection process

Applications for the positions below will be through a central application process run by the programme recruitment team.

Please note that to be eligible for appointment, successful applicants must comply with career stage and mobility criteria.

· Each applicant must submit a single application to the programme, which should include: (i) CV; (ii) detailed academic transcripts in the form of certified copies of all undergraduate and postgraduate level certificates; (iii) a motivation letter; (iv) a rank of 3 projects as instructed below; (v) name, title, contact details (address, telephone number, email address) and the capacity in which you know them for three referees and (vi) the Consent Form for Applicants (which can be found on www.bactivax.eu/opportunities  or attached to this job description) filled in and signed.

Only documents in English will be accepted.

· Each candidate should rank 3 projects that they would like to be considered for, in descending order, together with a short justification for their preference. Candidates should, therefore, be willing to undertake any of the projects they indicated preference for, if they are successful in the application process.

· Applications should be submitted as a single .pdf document by email to office@bactivax.eu

· Each applicant will be notified in writing of the outcome of their application. Incomplete applications will not be considered.

· Successful candidates will be invited for an interview at the recruitment meeting. Each interview will be attended by a panel including principal investigators from the BactiVax consortium. Interviews may also be carried using Skype or other online platforms.

BactiVax values gender balance and is committed to creating a diverse environment. All qualified applicants will receive equal opportunities and consideration for employment.

Projects (a detailed description and minimum requirements for each project can be found at https://www.bactivax.eu/projects)

ESR1 – Exploiting an innovative proteomic approach for novel Pseudomonas aeruginosa vaccine antigen identification 

  • Organisation/Institute: University College Dublin (Dublin, Ireland), www.ucd.ie
  • Supervisor: Assoc. Prof. Siobhán McClean

ESR2 – Novel glycoprotein vaccines to fight Burkholderia infections globally

  • Organisation/Institute: Queens University Belfast (Belfast, UK), www.qub.ac.uk
  • Supervisor: Prof. Miguel Valvano

ESR3 – Vaccine antigen identification against systemic infections

ESR4 – Structural and functional characterisation of novel vaccine antigens

  • Organisation/Institute: National Research Council, Institute of Biostructures and Bioimaging (Naples, Italy), www.ibb.cnr.it
  • Supervisor: Dr. Rita Berisio

ESR5 – NMR molecular recognition of antigens by key receptors

  • Organisation/Institute: CIC bioGUNE | Center for Cooperative Research in Biosciences (Bilbao, Spain), www.cicbiogune.es
  • Supervisor: Prof. Jesús Jiménez-Barbero

ESR6 – Development of Toll-Like Receptor-directed adjuvants and incorporation in innovative vaccine formulations

  • Organisation/Institute: University of Milano Bicocca (Milan, Italy), www.unimib.it/
  • Supervisor: Prof. Francesco Peri

ESR7 – Elucidation of the host response to facilitate more effective vaccines

  • Organisation/Institute: CIC bioGUNE | Center for Cooperative Research in Biosciences (Bilbao, Spain), www.cicbiogune.es
  • Supervisor: Prof. Juan Anguita

ESR8 – Production and characterisation of fusion protein antigens with a focus on increased solubility for large membrane proteins

  • Organisation/Institute: LIONEX GmBH (Braunschweig, Germany), www.lionex.de 
  • Supervisor: Prof. Mahavir Singh

ESR9 – Optimisation of host response and T-cell targeting

  • Organisation/Institute: Imperial College London (London, UK), www.imperial.ac.uk
  • Supervisors: Prof. Rosemary Boyton and Prof. Daniel Altmann

ESR10 – Post-exposure vaccination against multi-drug resistant tuberculosis

  • Organisation/Institute: St. George’s University of London (London, UK), www.sgul.ac.uk
  • Supervisor: Dr. Rajko Reljic

ESR11 – Bicyclic peptide vaccine antigens

  • Organisation/Institute: École Polytechnique Fédérale de Lausanne (Lausanne, Switzerland), www.epfl.ch
  • Supervisor: Prof. Christian Heinis

ESR12 – Optimisation of adjuvants for therapeutic vaccinations against respiratory infections

  • Organisation/Institute: University College Dublin (Dublin, Ireland), www.ucd.ie
  • Supervisor: Assoc. Prof. Siobhán McClean

ESR13 – Nanocapsulated peptide-based immunotherapeutics

  • Organisation/Institute: Eötvös Loránd University (Budapest, Hungary), www.elte.hu
  • Supervisor: Dr. Kata Horváti

ESR14 – Development of a therapeutic vaccine against P. aeruginosa

ESR15 – Development of in vitro immune monitoring for candidate vaccines and identification of correlates of protection

  • Organisation/Institute: ImmunXperts (Gosselies, Belgium), www.immunxperts.com
  • Supervisor: Dr. Séverine Giltaire

Benefits

  • Successful applicants will be offered a 36-month employee contract at one of the partner institutions where they will be registered as PhD students.

  • ESRs will receive a salary set out by the Marie Skłodowska-Curie Actions (MSCA) regulations. The salary includes living and mobility allowances and, if appropriate, a family allowance.

  • ESRs will have the opportunity to conduct cutting-edge research in the groups of leading experts in vaccinology, proteomics, medicine, microbiology, biochemistry, immunology, structural biology, medicinal, peptide and glycochemistry.  

  • ESRs will participate in workshops and training events covering scientific and transferrable skills, and will get the opportunity to disseminate their research at international conferences.

Eligibility criteria

Please note that all criteria below are mandatory:

  • Applicants should, at the time of recruitment, be in the first four years (full time equivalent research experience) of their research careers and not have been awarded a doctorate.
  • At the time of recruitment by the host organisation, they must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organisation for more than 12 months in the 3 years immediately prior to the recruitment date. Compulsory national service, short stays such as holidays, and time spent as part of a procedure for obtaining refugee status under the Geneva Convention are not taken into account.
  • Admission to the programme is open to applicants who hold a bachelor’s and/or master’s degree. A minimum of 240 ECTS and four years of legal duration in total is mandatory (please see each project for institutional requirements) or a comparable university degree (Second Cycle qualification), as required by the partner universities for admission to doctoral studies. The above-mentioned degrees must be obtained by the time of recruitment.
  • Requirements set by the consortium include a minimum of BSc Honours 2.1 and/or MSc degree (or equivalent) graduates in the fields of chemistry, medicinal chemistry, pharmacology, biochemistry, biology, microbiology, biomedical and biopharmaceutical sciences, medicine.
  • Applicants should be proficient in written and spoken English (minimum level of B2 or equivalent). Those who have passed an English proficiency test such as (but not limited to) IELTS Academic or TOEFL should enclose the relevant certificate with their application. English proficiency of short-listed applicants will be assessed during the selection interview. Please note that English-speaking countries might have specific language requirements.

Selection process

Applications for the positions below will be through a central application process run by the programme recruitment team.

Please note that to be eligible for appointment, successful applicants must comply with career stage and mobility criteria.

  • Each applicant must submit a single application to the programme, which should include: (i) CV; (ii) detailed academic transcripts in the form of certified copies of all undergraduate and postgraduate level certificates; (iii) a motivation letter; (iv) a rank of 3 projects as instructed below; (v) name, title, contact details (address, telephone number, email address) and the capacity in which you know them for three referees and (vi) the Consent Form for Applicants (which can be found on www.bactivax.eu/opportunities  or attached to this job description) filled in and signed.
  • Each candidate should rank 3 projects that they would like to be considered for, in descending order, together with a short justification for their preference. Candidates should, therefore, be willing to undertake any of the projects they indicated preference for, if they are successful in the application process.
  • Applications should be submitted as a single .pdf document by email to office@bactivax.eu
  • Each applicant will be notified in writing of the outcome of their application. Incomplete applications will not be considered.
  • Successful candidates will be invited for an interview at the recruitment meeting. Each interview will be attended by a panel including principal investigators from the BactiVax consortium. Interviews may also be carried using Skype or other online platforms.

BactiVax values gender balance and is committed to creating a diverse environment. All qualified applicants will receive equal opportunities and consideration for employment.

Web site for additional job details

Offer Requirements

  • REQUIRED EDUCATION LEVEL
    Biological sciences: Master Degree or equivalent
    Chemistry: Master Degree or equivalent
    Pharmacological sciences: Master Degree or equivalent
    Medical sciences: Master Degree or equivalent
  • REQUIRED LANGUAGES
    ENGLISH: Excellent

Skills/Qualifications

  • ·Admission to the programme is open to applicants who hold a bachelor’s and/or master’s degree. A minimum of 240 ECTS and four years of legal duration in total is mandatory (please see each project for institutional requirements) or a comparable university degree (Second Cycle qualification), as required by the partner universities for admission to doctoral studies. The above-mentioned degrees must be obtained by the time of recruitment.
  • Requirements set by the consortium include a minimum of BSc Honours 2.1 and/or MSc degree (or equivalent) graduates in the fields of chemistry, medicinal chemistry, pharmacology, biochemistry, biology, microbiology, biomedical and biopharmaceutical sciences, medicine.
  • Applicants should be proficient in written and spoken English (minimum level of B2 or equivalent). Those who have passed an English proficiency test such as (but not limited to) IELTS Academic or TOEFL should enclose the relevant certificate with their application. English proficiency of short-listed applicants will be assessed during the selection interview. Please note that English-speaking countries might have specific language requirements.

Specific Requirements

  • Applicants should, at the time of recruitment, be in the first four years (full time equivalent research experience) of their research careers and not have been awarded a doctorate.
  • At the time of recruitment by the host organisation, they must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organisation for more than 12 months in the 3 years immediately prior to the recruitment date. Compulsory national service, short stays such as holidays, and time spent as part of a procedure for obtaining refugee status under the Geneva Convention are not taken into account.

Work location(s)
2 position(s) available at
University College Dublin
Ireland
Dublin
1 position(s) available at
National Research Council, Institute of Biostructures and Bioimaging (CNR-IBB)
Italy
Naples
1 position(s) available at
Queen's University Belfast
United Kingdom
Belfast
2 position(s) available at
CIC bioGUNE | Center for Cooperative Research in Biosciences
Spain
Bilbao
1 position(s) available at
St. George's University of London
United Kingdom
London
1 position(s) available at
Imperial College London
United Kingdom
London
2 position(s) available at
Ludwig Maximilian University of Munich
Germany
Munich
1 position(s) available at
University of Milano Bicocca
Italy
Milan
1 position(s) available at
École Polytechnique Fédérale de Lausanne
Switzerland
Lausanne
1 position(s) available at
Eötvös Loránd University
Hungary
Budapest
1 position(s) available at
LIONEX GmBH
Germany
Braunschweig
1 position(s) available at
ImmunXperts
Belgium
Gosselies

EURAXESS offer ID: 467225

Disclaimer:

The responsibility for the jobs published on this website, including the job description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.

 

Please contact support@euraxess.org if you wish to download all jobs in XML.